Skip to content

Study note

Effects of Caffeine Supplementation on Neuromuscular Performance in Powerlifting Athletes: A Randomized, Placebo-Controlled, Quadruple-Blinded, Cross-Over Study.

PMID 40845293 (2025): caffeine — Time-trial performance (study note for endurance athletes).

Updated Jul 22, 2026

Read the study note

Study note • PMID 40845293

Effects of Caffeine Supplementation on Neuromuscular Performance in Powerlifting Athletes: A Randomized, Placebo-Controlled, Quadruple-Blinded, Cross-Over Study.

Journal of strength and conditioning research2025 • DOI 10.1519/JSC.0000000000005222

How to use this page

This note summarizes one study record. Check the participants, methods, results, and limitations before applying it to training.

  • Design signal: randomized trial.
  • Population relevance: athlete/trained context.
  • Consistency: single-study evidence.
  • Practical recommendation depends on tolerance, context, and whether it protects training consistency.

ELI5

In plain language

Enes, A, Hubner, P, Oneda, G, Bernardo, MF, Macedo, ACG, Salles, GN, Ferreira, LHB, Rezende, EF, Mohan, AE, Pinero, A, Leonel, DF, Cruz, R, Schoenfeld, BJ, and Souza-Junior, TP. (randomized trial; athletes).

Effects on Time-trial performance are mixed or unclear from the abstract alone. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: Enes, A, Hubner, P, Oneda, G, Bernardo, MF, Macedo, ACG, Salles, GN, Ferreira, LHB, Rezende, EF, Mohan, AE, Pinero, A, Leonel, DF, Cruz, R, Schoenfeld, BJ, and Souza-Junior, TP.
  • Effects on Time-trial performance are mixed or unclear from the abstract alone.
  • Population: athletes.
  • Protocol cues (title/abstract): 8 mg • 1 week • 60 minutes.

Protocol

Protocol (as reported)

  • Intervention/exposure: caffeine (vs placebo).
  • Dose/time/duration cues in abstract/title: 8 mg • 1 week • 60 minutes.
  • Outcomes: Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it may help, and who should be cautious

Who it helps

  • Athletes similar to the study population (athletes) working on supplements.
  • Athletes who can measure Time-trial performance with a repeatable workout or time-trial effort.

Who should be cautious

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: randomized trial (placebo-controlled).
  • Population: athletes.
  • Comparator: placebo.
  • Outcomes measured: Time-trial performance.
  • Protocol cues mentioned: 8 mg • 1 week • 60 minutes.
  • Source: PubMed PMID 40845293 (2025) — Journal of strength and conditioning research.

Results excerpt

What the abstract reports

For RPE, there was a main effect of condition where CAF intake led to lower scores for back squat (p = 0.003) and deadlift (p = 0.042).

Note: excerpts are short; for full context, read the paper.

Limits

Limitations and bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Adaptive AI coach for iPhone

Meet your adaptive AI coach.

Tell your coach what you are training for. It builds the plan, follows the work you complete, and adapts upcoming training when recovery, your schedule, or real life changes.

Keep going

Sources